ALIMTA® (pemetrexed for injection)

Update your billing and coding systems to include the permanent CYRAMZA® (ramucirumab) J-code: J9308, injection, ramucirumab, 5 mg. Issued by the Centers for Medicare & Medicaid Services (CMS), this permanent J-code is effective as of January 1, 2016.

ALIMTA® (pemetrexed for injection)

Services

Patients who are prescribed ALIMTA for FDA-approved indications may be eligible for reimbursement services, financial assistance, or product through the Lilly Cares Foundation.*

The Lilly Cares Foundation, Inc., a separate nonprofit organization, provides free Lilly medications to qualifying patients. Lilly PatientOne collects information on behalf of Lilly Cares to assist Lilly Cares with its charitable mission. For more information about Lilly Cares, please visit LillyCares.com.

Learn more
Billing Information Ordering Information
HCPCS Codes
Code Description
J-9305 ALIMTA (pemetrexed for injection) 500 mg vial (billing unit = 10 mg)
J-9305 ALIMTA (pemetrexed for injection) 100 mg vial (billing unit = 10 mg)
NDC
Code Dosage form and strength
00002-7623-01 ALIMTA (pemetrexed for injection) 500 mg vial
00002-7640-01 ALIMTA (pemetrexed for injection) 100 mg vial
Diagnosis Codes
Non-small cell lung cancer
ICD-10-CM Description
C34.00 - unspecified Malignant neoplasm of main bronchus
C34.01 - right
C34.02 - left
C34.10 - unspecified Malignant neoplasm of upper lobe, bronchus, or lung
C34.11 - right
C34.12 - left
C34.2 Malignant neoplasm of middle lobe, bronchus, or lung
C34.30 - unspecified Malignant neoplasm of lower lobe, bronchus, or lung
C34.31 - right
C34.32 - left
C34.80 - unspecified Malignant neoplasm of other parts of bronchus or lung (overlapping sites)
C34.81 - right
C34.82 - left
C34.90 - unspecified Malignant neoplasm of bronchus or lung, unspecified
C34.91 - right
C34.92 - left
Malignant pleural mesothelioma
ICD-10-CM Description
C38.4 - Malignant neoplasm of pleura Malignant neoplasm of parietal pleura
C45.0 - Mesothelioma of pleura
C38.4 - Malignant neoplasm of pleura Malignant neoplasm of visceral pleura
C45.0 - Mesothelioma of pleura
C38.4 - Malignant neoplasm of pleura Malignant neoplasm of other specified sites of pleura
C45.0 - Mesothelioma of pleura
C38.4 - Malignant neoplasm of pleura Malignant neoplasm of pleura, unspecified
C45.0 - Mesothelioma of pleura
Drug Administration CPT® Codes
Code Description
96409 Chemotherapy administration, intravenous, push technique, single or initial substance/drug
96411 Chemotherapy administration, intravenous, push technique, each additional substance/drug
96413 Chemotherapy administration, intravenous infusion technique; up to 1 hr, single or initial substance/drug
96415 Chemotherapy administration, intravenous infusion technique, each additional hour
96417 Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hr
Product Codes
Lilly Product Code LY231514
ALIMTA UPN, GTIN CS Unit 100 mg: 00300027640013
500 mg: 00300027623016
ALIMTA UPC 100 mg: 0002-7640-01
500 mg: 0002-7623-01
National Drug Code 100 mg: 0002-7640-01
500 mg: 0002-7623-01

Prescribing Information

Patient Prescribing Information

This information is presented for informational purposes only and is not intended to provide reimbursement or legal advice. Laws, regulations, and policies concerning reimbursement are complex and are updated frequently. Individual coding decisions should be based upon diagnosis and treatment of individual patients. Eli Lilly and Company does not guarantee success in obtaining insurance payments. While we have made an effort to be current as of the issue date of this website, the information may not be as current or comprehensive when you view it. Providers should contact third-party payers for specific information on their coverage, coding, and payment policies. Please consult with your legal counsel or reimbursement specialist for any reimbursement or billing questions. For more information please call the Lilly PatientOne program at 1-866-472-8663.

†  FDA standard NDC has been "zero-filled" to ensure creation of an 11-digit code that meets HIPAA standards. The zero-fill location is indicated in bold.